AnaptysBio's change in receivables for the quarter that ended in Sep. 2024 was $-3.19 Mil. It means AnaptysBio's Accounts Receivable
increased by $3.19 Mil
from Jun. 2024 to Sep. 2024 .
AnaptysBio's change in receivables for the fiscal year that ended in Dec. 2023 was $-5.43 Mil. It means AnaptysBio's Accounts Receivable
increased by $5.43 Mil
from Dec. 2022 to Dec. 2023 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
AnaptysBio's Days Sales Outstanding for the
three
months ended in Sep. 2024 was 37.07.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. AnaptysBio's liquidation value for the
three
months ended in Sep. 2024 was $30.21 Mil.
AnaptysBio Change In Receivables Historical Data
The historical data trend for AnaptysBio's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AnaptysBio (NAS:ANAB) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
AnaptysBio's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AnaptysBio Change In Receivables Related Terms
Thank you for viewing the detailed overview of AnaptysBio's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANAB has been successfully added to your 